# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Needham analyst David Saxon maintains Dentsply Sirona (NASDAQ:XRAY) with a Buy and lowers the price target from $36 to $34.
Dentsply Sirona misses Q2 earnings, announces restructuring amid weak demand.
- 10Q Filing
Baird analyst Jeffrey Johnson maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $33 to...